IE
AMLX icon

Israel Englander’s Amylyx Pharmaceuticals AMLX Stock Holding History

Israel Englander’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,455
Closed -$561K – 5668
2025
Q4 		$561K Sell
46,455
-371,316
-89% -$5.04M ﹤0.01% 4868
2025
Q3 		$5.68M Sell
417,771
-1,094,287
-72% -$10.3M ﹤0.01% 3003
2025
Q2 		$9.69M Sell
1,512,058
-1,569,795
-51% -$7.64M ﹤0.01% 2290
2025
Q1 		$10.9M Buy
3,081,853
+2,487,617
+419% +$8.85M 0.01% 2094
2024
Q4 		$2.25M Buy
594,236
+137,420
+30% +$647K ﹤0.01% 3543
2024
Q3 		$1.48M Sell
456,816
-1,078,362
-70% -$2.42M ﹤0.01% 3966
2024
Q2 		$2.92M Sell
1,535,178
-936,277
-38% -$1.81M ﹤0.01% 3196
2024
Q1 		$7.02M Buy
2,471,455
+198,812
+9% +$2.6M ﹤0.01% 2519
2023
Q4 		$33.5M Buy
2,272,643
+153,108
+7% +$2.35M 0.01% 1106
2023
Q3 		$38.8M Buy
2,119,535
+197,904
+10% +$4.18M 0.02% 883
2023
Q2 		$41.4M Buy
1,921,631
+847,021
+79% +$22.9M 0.02% 859
2023
Q1 		$31.5M Buy
1,074,610
+215,195
+25% +$7.48M 0.02% 986
2022
Q4 		$31.8M Sell
859,415
-61,713
-7% -$2.19M 0.02% 1084
2022
Q3 		$25.9M Buy
921,128
+475,084
+107% +$11.9M 0.02% 1106
2022
Q2 		$8.59M Buy
446,044
+308,803
+225% +$3.67M 0.01% 2229
2022
Q1 		$1.76M Buy
+137,241
New +$3.1M ﹤0.01% 4010

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Israel Englander's AMLX Position: Q1 2026 in Review

Israel Englander sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2026, closing a stake of 46,455 shares — an estimated $561K sold.

Israel Englander first reported a position in AMLX in Q1 2022 and held it in 16 quarters. The position peaked at $41.4M in Q2 2023. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Israel Englander reported no remaining Amylyx Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Israel Englander sold 46,455 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $561K.
  • Israel Englander first reported a position in Amylyx Pharmaceuticals in Q1 2022 and held it in 16 quarters.
  • Israel Englander's Amylyx Pharmaceuticals position peaked at $41.4M in Q2 2023.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.